As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.
19 Analysts have issued a Wave Life Sciences Ltd. forecast:
19 Analysts have issued a Wave Life Sciences Ltd. forecast:
Jun '25 |
+/-
%
|
||
Revenue | 94 94 |
15%
15%
|
|
Gross Profit | - - |
-
|
|
EBITDA | -133 -133 |
67%
67%
|
EBIT (Operating Income) EBIT | -144 -144 |
71%
71%
|
Net Profit | -130 -130 |
76%
76%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Head office | Singapore |
CEO | Paul Bolno |
Employees | 288 |
Founded | 2012 |
Website | www.wavelifesciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.